Page 58 - Roche Diagnostics News Today

IVD Infectious Disease Market: Growing prevalence of targeted diseases to drive the market - read this article along with other careers information, tips and advice on BioSpace

Background The severe acute respiratory syndrome caused by the novel coronavirus (COVID-19), due to its fast spread, is a disease with global health, social and economic burden. This is complicated by its high morbidity and mortality among those with medical comorbidities and older adults. During the outbreak in Libya, intensive care facilities were overwhelmed by the number of patients requiring special care. Admission to such facilities was reserved for severe cases showing low blood oxygen ...

Investegate announcements from MarketsandMarkets™, Point of Care and Rapid Diagnostics Market worth $72.0 billion by 2027 - Exclusive Report by MarketsandMarkets™

The Latin America market is expected to grow at the highest CAGR during the forecast periodNorthbrook, April 04, 2022by Product (Glucose, Infectious Disease(HIV, Hepatitis C), Pregnancy Test), Platform

Press release content from Globe Newswire. The AP news staff was not involved in its creation.

The Latin America market is expected to grow at the highest CAGR during the forecast period...

The antifibrinolytic agent significantly reduced the risk for bleeding in a wide array of major noncardiac surgeries, suggesting an expanded role for TXA.

This randomized clinical trial examines the effect of early administration of the PCSK9 inhibitor alirocumab on coronary atherosclerosis using serial multimodal

Non-Executive Director Oliver Buck to retire at the Annual General Meeting Tiffany Olson, experienced U.S.-based pharma executive appointed as independent Non-Executive...

/PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces that Tiffany Olson has been appointed to the Board, as a...